Weekend ICYMI: August 19 to August 23
In case you missed it, this week we had news about illegal online GLP-1 sales, pharmacy deserts, innovative medication cooling technologies, and more.
Small Doses: August 19 to August 23
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Pharmacy Deserts Prominent in Areas of High Social Vulnerability
Researchers analyzed data from every county in the US and aimed to address the association between high social vulnerability and pharmacy deserts.
FDA Roundup: Updated COVID-19 Vaccines, Treprostinil for PAH Associated With PH-ILD
Check out important updates from the FDA for the week of August 19.
Q&A: The Importance of Cooling Technology for Prescription Drugs
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the importance of cooling medications in the rising heat of the summer months.
Disparities Hinder HPV Vaccine Goals in USAPI Jurisdictions
Access inequities are preventing the US-affiliated Pacific Island (USAPI) jurisdictions from meeting the WHO 2030 goal of 90% human papillomavirus (HPV) vaccination series completion coverage.
Q&A: How Phononic is Revolutionizing Heating and Cooling for Pharmaceuticals
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the role his company’s technology plays in the pharmaceutical industry.
Meat Consumption Linked with Higher Risk of Developing Type 2 Diabetes
Increased incidence of typed 2 diabetes was associated with higher consumption of processed meat, unprocessed red meat, and poultry.
Tirzepatide Demonstrates 94% Diabetes Reduction, 22% Weight Loss in SURMOUNT-1 Study
A detailed report of study findings will be published in a peer-reviewed journal and presented at ObesityWeek 2024.
Q&A: Discussing the Dangers of Buying GLP-1s From Online Pharmacies
Timothy Mackey, MAS, PhD, discusses a study that sought to determine the risk of sourcing semaglutide from online platforms.
Majority of Savings from CMS Price Negotiations Comes From 3 Drugs
Research experts at the Brookings Institution in Washington, D.C., analyzed the savings estimates provided by CMS for its drug price negotiations and compared them with the institution’s own estimates.
Amneal Pharmaceuticals Receives FDA Approval for Propofol Injectable Emulsion Single-Dose Vials
FDA approval of Amneal Pharmaceuticals' propofol injectable emulsion single-dose vials aims to address the drug’s history of chronic supply issues.
Otezla for Treatment of Pediatric Plaque Psoriasis Now Available in US
The approval of apremilast to treat plaque psoriasis in children and adolescents aged 6 years and older was based on data from the phase 3 SPROUT trial.
FDA Grants Tentative Approval to Treprostinil for PAH Associated With PH-ILD
Final approval of the therapy may occur after expiration of the 3-year regulatory exclusivity for Tyvaso DPI on May 23, 2025.
APhA Campaign Aims to Spread Awareness About Harmful PBM Practices
The American Pharmacists Association is dedicating further time and resources to its ongoing fight for federal PBM reform.
Online Resources Could Help Address Gaps in Pain Management
Focus group participants were receptive to using eHealth tools, but noted several barriers such as cost and availability.
Health Care Costs, Financial Scams Top List of Health Concerns Among Older Adults
Participants were asked to rate their level of concern on 26 health topics.
Weekend ICYMI: August 12 to August 16
In case you missed it, this week we had news about digital therapeutics for depression, bracing for fall allergies, at-home tests for sexually transmitted infections, and more.
FDA Grants Marketing Authorization to First-Ever OTC Syphilis Test
First To Know Syphilis Tests are expected to be available at major national retailers and online in late 2024.
How PBMs Impact Independent Pharmacies
Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, discussed his experience as an independent pharmacy owner working under the thumb of pharmacy benefit managers.
FDA Roundup: First Treatment for Hypoparathyroidism, Disposable CGM Approval
Check out important updates from the FDA for the week of August 12.
MedAdvisor, BEN Partner to Introduce AI-Driven Medication Advisor
The partnership’s revolutionary new product is set to premiere at the National Association of Chain Drug Stores’ Total Store Expo in Boston, Massachusetts, kicking off on August 17, 2024.
Social, Economic Barriers Impact Access to Opioid Use Disorder Medications
Community pharmacies in counties with high racialized economic segregation had higher odds of restricting buprenorphine.
Despite Success of Vaccines for Children Program, Disparities Persist
A CDC report called for “increased efforts” to ensure parents can obtain all recommended vaccines for their eligible children and realize the full potential of the VFC program.
Prices Released for First 10 Drugs Selected in Medicare Negotiations
New prices will go into effect on January 1, 2026, for individuals covered by Medicare Part D prescription drugs.
Hidradenitis Suppurativa Treatment Shows Positive Results in Phase 3 Trial
Izokibep from Affibody is a small therapeutic protein designed to inhibit IL-17A.
FDA Approves Medtronic’s Disposable CGM
Medtronic also announced it has entered a global partnership with Abbott in an effort to expand CGM device options for patients living with diabetes.
Q&A: An Independent Pharmacist’s Hopes for PBM Reform
Tom DePietro, PharmD, owner of DePietro’s Pharmacy in Dunmore, Pennsylvania, talked about current movement toward PBM reform and his hopes for the future of pharmacy.
Dengue Vaccine TAK-003 Confirmed to be Safe, Effective
TAK-003 could be a powerful combatant against the increasing global threat of dengue virus.
First FDA-Approved Digital Therapeutic to Treat Depression Now Available in App Stores
Rejoyn, developed by Otsuka Pharmaceutical and Click Therapeutics, is only accessible with a prescription from a health care provider.
